viimane versioon :
19/11/2024
vähiravimite   Gemcitabine hydrochloride  
Süsteravim
Stabiilsus lahustes Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Manustamis viis Viited pdf
   keemiline struktuur  

Kaubanduslikud nimed erinevates maades   Kaubanduslikud nimed erinevates maades     

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Accogem Mehhiko
Antoril Argentiina
Axigem Saksamaa
Bendacitabin Saksamaa
Binoptos Mehhiko
Celzar Maroko
Dercin Rumeenia
Dhacibine Malaisia
Emcitab Kolumbia
Eriogem Argentiina, Ecuador
Fotinex Argentiina, Maroko
Gebina Argentiina
Gebitan Kolumbia
Gembio Argentiina, Ecuador, Tšiili
Gemcimira Maroko, Tšiili
Gemcit Portugal
Gemcitabin Saksamaa
Gemcitac Tšiili
Gemko Türgi
Gemsibin Türgi
Gemsol Austria
Gemtero Maroko, Tšiili
Gemzar Ameerika ühendriigid, Araabia Ühendemiraadid, Austraalia, Austria, Belgia, Brasiilia, Ecuador, Egiptus, Hispaania, Holland, Horvaatia, Iirimaa, Iraan, Island, Itaalia, Kanada, Kolumbia, Kreeka, Lõuna Aafrika Vabariik, Luksemburg, Malaisia, Maroko, Mehhiko, Norra, Poola, Portugal, Prantsusmaa, Rootsi, Rumeenia, Saksamaa, Sloveenia, Soome, Suurbritannia, Sveits, Taani, Tai, Tšiili, Tuneesia, Türgi, Ungari, uus-Meremaa, Venetsueela
Gentabin Kolumbia
Haxanit Argentiina, Maroko
Lenfotabin Mehhiko
Viited   Süsteravim   Viited : Gemcitabine hydrochloride  
tüüp avaldamine
1422 ajaleht Xu QA, Zhang Y, Trissel LA.
Physical and chemical stability of gemcitabine hydrochloride solutions.
J Am Pharm Assoc 1999 ; 39: 509-513.
1423 ajaleht Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1501 ajaleht Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.
Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials.
Int J Pharm 1999 ; 185: 113-121.
1520 Labor Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1611 ajaleht Chalmers JR, Bobek MB, Militello MA.
Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs.
Am J Health-Syst Pharm 2001 ; 58: 504-506.
1625 ajaleht Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1662 ajaleht Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1663 ajaleht Ponton JL, Munoz C, Rey M, Val M.
The stability of (lyophilized) gemcitabine in 0.9% sodium chloride injection.
EJHP 2002 ; 1: 23-25.
1925 ajaleht Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1953 ajaleht Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982 ajaleht Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2009 ajaleht Trissel LA, Zhang Y.
Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration.
Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.
2262 ajaleht Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
2344 Labor Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.
Ebewe Pharma 2009
3262 ajaleht Manners S, Galettis P, de Souza P.
Conditions causing gemcitabine crystallization.
J Oncol Pharm Practice 2011 ; 17, 4: 395-399.
3496 Labor Gemcitabin Actavis solution - Stability Study
Actavis 2009
3670 ajaleht Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30.
4310 ajaleht Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M.
Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.
Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.
4736 ajaleht Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L.
An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions.
J Pharm Biomed Anal 2023

  Mentions Légales